Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers. | Int J Cardiovasc Imaging | 2021 | 33559798 | PubTator, text mining | PubMed |
| Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. | Nat Commun | 2021 | 33558530 | PubTator, text mining | PubMed |
| Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes. | PeerJ | 2021 | 33552729 | PubTator, text mining | PubMed |
| Noonan syndrome patient-specific induced cardiomyocyte model carrying SOS1 gene variant c.1654A>G. | Exp Cell Res | 2021 | 33549576 | PubTator, text mining | PubMed |
| Septal myectomy in the era of genetic testing. | J Card Surg | 2021 | 33547670 | PubTator, text mining | PubMed |
| Risk-Based Approach for the Prediction and Prevention of Heart Failure. | Circ Heart Fail | 2021 | 33535771 | PubTator, text mining | PubMed |
| Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach. | Proteomes | 2021 | 33535467 | PubTator, text mining | PubMed |
| BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and status. | Neth Heart J | 2021 | 33532905 | PubTator, text mining | PubMed |
| Proceedings of the 24th Annual Meeting of the Portuguese Society of Human Genetics (SPGH - Sociedade Portuguesa de Genética Humana). | Medicine (Baltimore) | 2021 | 33530161 | PubTator, text mining | PubMed |
| Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy. | Int J Cardiol | 2021 | 33529666 | PubTator, text mining | PubMed |
| The N terminus of myosin-binding protein C extends toward actin filaments in intact cardiac muscle. | J Gen Physiol | 2021 | 33528507 | PubTator, text mining | PubMed |
| Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin. | Sci Adv | 2021 | 33523960 | PubTator, text mining | PubMed |
| Dynamic Changes to the Skeletal Muscle Proteome and Ubiquitinome Induced by the E3 Ligase, ASB2β. | Mol Cell Proteomics | 2021 | 33516941 | PubTator, text mining | PubMed |
| Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine. | J Gen Physiol | 2021 | 33512404 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. | Sci Transl Med | 2021 | 33504652 | PubTator, text mining | PubMed |
| Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies. | Genet Med | 2021 | 33500567 | PubTator, text mining | PubMed |
| Proteome-wide profiling and mapping of post translational modifications in human hearts. | Sci Rep | 2021 | 33500497 | PubTator, text mining | PubMed |
| MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma. | Technol Cancer Res Treat | 2021 | 33499774 | PubTator, text mining | PubMed |
| Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. | Nat Genet | 2021 | 33495597 | PubTator, text mining | PubMed |
| Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. | Nat Genet | 2021 | 33495596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=73